Phibro Animal Health Corporation ( PAHC) - Stock Earnings
PAHC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 26.5 million USD | 363.9 million USD |
| 2025Q4 | 27.5 million USD | 373.9 million USD |
| 2026Q1 | 24.0 million USD | 383.5 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PAHC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 32.6 million USD | 977.9 million USD |
| 2024 | 2.4 million USD | 1.0 billion USD |
| 2025 | 48.3 million USD | 1.3 billion USD |
| 2026 Est. | — | — |
PAHC
Price: $32.07
Dividend Yield: 1.45%
Forward Dividend Yield: 1.50%
Payout Ratio: 800.00%
Dividend Per Share: 0.48 USD
Earnings Per Share: 2.33 USD
P/E Ratio: 15.59
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 1.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR10: 1.93%